Squarepoint’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,400
Closed -$141K 4541
2025
Q1
$141K Sell
10,400
-39,400
-79% -$654K ﹤0.01% 4128
2024
Q4
$842K Sell
49,800
-16,200
-25% -$315K ﹤0.01% 3231
2024
Q3
$1.34M Buy
66,000
+2,300
+4% +$47K ﹤0.01% 2375
2024
Q2
$1.44M Sell
63,700
-2,600
-4% -$68.1K ﹤0.01% 2299
2024
Q1
$1.74M Sell
66,300
-95,600
-59% -$2.72M ﹤0.01% 2180
2023
Q4
$5.11M Buy
161,900
+5,600
+4% +$152K 0.01% 1391
2023
Q3
$4.38M Sell
156,300
-12,600
-7% -$433K 0.01% 1263
2023
Q2
$6.23M Buy
168,900
+46,200
+38% +$1.41M 0.02% 951
2023
Q1
$3.67M Sell
122,700
-6,800
-5% -$224K 0.02% 1053
2022
Q4
$3.97M Buy
129,500
+62,500
+93% +$1.88M 0.02% 955
2022
Q3
$1.65M Sell
67,000
-82,800
-55% -$2.73M 0.01% 1440
2022
Q2
$4.8M Buy
+149,800
New +$5.51M 0.03% 697

Other funds holding CC

Squarepoint's CC Position: Q4 2025 in Review

Squarepoint sold out of Chemours (CC) in Q4 2025, closing a stake of 541,689 shares — an estimated $8.58M sold.

Squarepoint first reported a position in CC in Q3 2016 and held it in 31 quarters. The position peaked at $18.3M in Q4 2023. 435 funds tracked by Wall St. Rank hold CC as of Q4 2025.

  • Squarepoint reported no remaining Chemours position as of Q4 2025 after selling out during the quarter.
  • Squarepoint sold 541,689 Chemours shares in Q4 2025, an estimated $8.58M.
  • Squarepoint first reported a position in Chemours in Q3 2016 and held it in 31 quarters.
  • Squarepoint's Chemours position peaked at $18.3M in Q4 2023.
  • 435 funds tracked by Wall St. Rank held Chemours as of Q4 2025.

Based on Squarepoint's 13F filing for Q4 2025, filed 13 Feb 2026.